Neoadjuvant Paclitaxel–Carboplatin Followed by Concurrent Chemoradiotherapy versus Concurrent Chemoradiotherapy Alone in ...
Introduction Cervical cancer remains one of the leading causes of cancer-related morbidity and mortality among women, accounting for about 17.2% of all malignancies and 19.1% of cancer deaths worldwide.1 Recent study have identified several signaling …